Literature DB >> 3899457

Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.

J G Wagner.   

Abstract

The literature on theophylline is confusing since in the same dose range one article will report linear kinetics while another will report non-linear kinetics. Single dose clearances and lower steady-state clearances of theophylline, recently reported in the literature, were used to estimate pooled Vmax and Km values of the Michaelis-Menten equation for 10 normal subjects. The mean Vmax was 1960 mg/day and the mean Km was 24.1 mg/L. These values were then utilised to: explain another set of different oral clearances following doses of 2 and 6 mg/kg reported in the literature; estimate relative effects of dose rate and type of input on absolute bioavailability; estimate AUC (0-infinity) as a function of single dose over the range 0 to 1500 mg; estimate the average steady-state serum concentration of theophylline (Cssav and steady-state oral clearance (CLsspo) as a function of dose rate in mg/day; illustrate how Michaelis-Menten kinetics alters the apparent first-order elimination rate constant and the half-life estimated from terminal log-linear plots at concentrations appreciably lower than the Km value; and illustrate how Michaelis-Menten kinetics affects the estimation of a zero-order absorption rate constant using the Wagner-Nelson method.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899457     DOI: 10.2165/00003088-198510050-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  24 in total

1.  Dose-dependent kinetics of theophylline disposition in asthmatic children.

Authors:  M Weinberger; E Ginchansky
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.

Authors:  J G Wagner; G J Szpunar; J J Ferry
Journal:  Drug Metab Dispos       Date:  1984 Jul-Aug       Impact factor: 3.922

3.  Food-induced dose dumping of once-a-day theophylline.

Authors:  L Hendeles; P Wubbena; M Weinberger
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

4.  The relation of product formulation to absorption of oral theophylline.

Authors:  M Weinberger; L Hendeles; L Bighley
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

5.  Predictability of verapamil steady-state plasma levels from single-dose data explained.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1984-07       Impact factor: 6.875

6.  Dose dependency for absorption and elimination rates of theophylline. Implications for studies of bioavailability.

Authors:  G Milavetz; M Weinberger; L Vaughan
Journal:  Pharmacotherapy       Date:  1984 Jul-Aug       Impact factor: 4.705

7.  Nonlinear theophylline elimination.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1982-03       Impact factor: 6.875

8.  Influence of chronic dosing on theophylline clearance.

Authors:  H Efthimiou; D J Morgan; L Ioannides-Demos; K Raymond; A J McLean
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

9.  Verapamil kinetics in normal subjects and patients with coronary artery spasm.

Authors:  S B Freedman; D R Richmond; J J Ashley; D T Kelly
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

10.  Dose-dependent elimination kinetics of theophylline.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

View more
  6 in total

Review 1.  Adverse reactions and interactions with theophylline.

Authors:  M H Skinner
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

2.  Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.

Authors:  J H Jonkman; K G Nicholson; P R Farrow; M Eckert; G Grasmeijer; B Oosterhuis; O E De Noord; T W Guentert
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

3.  Non-linear elimination and protein binding of probenecid.

Authors:  B M Emanuelsson; B Beermann; L K Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

5.  Computer-aided dosage form design. I. Methods for defining a long-acting first-order delivery system of maximum formulating flexibility.

Authors:  T Y Lee; R E Notari
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

Review 6.  Food interactions with sustained-release theophylline preparations. A review.

Authors:  J H Jonkman
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.